ALPHACENTRIC ADVISORS LLC – United Therapeutics Corporation Transaction History
ALPHACENTRIC ADVISORS LLC portfolio value:
$471,000
portfolio value
ALPHACENTRIC ADVISORS LLC quarter portfolio value change:
-2.70%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +104.55% | 1.15K shares | 233K | $209.38 | 2.25K |
| Q4 2021 | share | Increase | +100.00% | 550 shares | 136K | $215.18 | 1.1K |
| Q3 2021 | share | 0.00% | 0 shares | 3K | $184.58 | 550 | |
| Q2 2021 | share | 0.00% | 0 shares | 7K | $179.41 | 550 | |
| Q1 2021 | share | Decrease | -26.67% | -200 shares | -22K | $167.27 | 550 |
| Q4 2020 | share | Decrease | -9.20% | -76 shares | 31K | $151.79 | 750 |
| Q3 2020 | share | Increase | 0.00% | 826 shares | 83K | $101 | 826 |